Michelle Prowant
Acute Care · Lima, OHNPI 1982221057
Payments from drug & device makers
Across 151 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$472
- Novartis$434
- Bayer$275
- Lilly USA, LLC$159
- Renalytix AI, Inc.$148
- Incyte Corporation$148
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,10891%
- Education$2909%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 21 | $472 |
| Novartis | 21 | $434 |
| Bayer | 13 | $275 |
| Lilly USA, LLC | 3 | $159 |
| Renalytix AI, Inc. | 7 | $148 |
| Incyte Corporation | 7 | $148 |
| Mallinckrodt Hospital Products Inc. | 7 | $146 |
| AbbVie | 5 | $137 |
| Calliditas Therapeutics US Inc. | 6 | $131 |
| Baxter Healthcare | 2 | $117 |
| Johnson & Johnson | 6 | $115 |
| Aurinia Pharma U.S., Inc. | 2 | $110 |
| Amgen(2 entities) | 4 | $106 |
| OPKO Pharmaceuticals, LLC | 6 | $100 |
| Novo Nordisk | 5 | $91 |
| Merck | 4 | $69 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Pfizer | 3 | $47 |
| AVEO Pharmaceuticals, Inc. | 2 | $47 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Bristol Myers Squibb | 2 | $33 |
| Sobi, Inc | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Genmab U.S., Inc. | 1 | $26 |
| Medtronic | 1 | $25 |
| Sanofi | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Gilead | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Galvanize Therapeutics, Inc | 1 | $15 |
| Novocure Inc. | 1 | $15 |
How this compares
$3,398 in reported general payments places this provider in the 90th percentile of 1,101 acute care providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Lima
- Brittany ZeiglerLima$7K
- Kristin HoehnLima$6K
- Gerri HempflingLima$5K
- Andrea RobinsonCleveland$149K
- Brittney BrowneMonroe$142K
- Jamie McGuireMiamisburg$86K
- Ileah ReichertColumbus$73K
- Davida PraterBeavercreek$46K
- Dawn FrenchAlliance$40K
- Holly McKibbenColumbus$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.